Sangamo Therapeutics, Inc. (SGMO) Covered Calls
Sangamo BioSciences, Inc is engaged in the research, development and commercialization of novel transcription factors for gene regulation and gene modification.
You can sell covered calls on Sangamo Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SGMO (prices last updated Thu 4:16 PM ET):
| Sangamo Therapeutics, Inc. (SGMO) Stock Quote | ||||||
|---|---|---|---|---|---|---|
| Last | Change | Bid | Ask | Volume | P/E | Market Cap |
| 0.50 | +0.01 | 0.48 | 0.55 | 964K | - | 0.1 |
| Covered Calls For Sangamo Therapeutics, Inc. (SGMO) | ||||||
|---|---|---|---|---|---|---|
| Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
| May 17 | 0.5 | 0.00 | 0.55 | -9.1% | -144.4% | |
| Jun 21 | 0.5 | 0.05 | 0.50 | 0.0% | 0.0% | |
| Subscribers get access to the full covered call chain, and more features. | ||||||
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Sangamo BioSciences, Inc. is a clinical stage biopharmaceutical company focused on the research, development and commercialization of engineered DNA-binding proteins as novel therapeutics to treat unmet medical needs. It is engaged in developing zinc finger DNA-binding proteins (ZFPs) for therapeutic gene regulation and modification. Its zinc finger DNA-binding proteins (ZFPs) could be engineered to make ZFP nucleases (ZFNs) proteins, which could be used to modify DNA sequences in various ways for genome editing and gene regulation and ZFP transcription factors (ZFP TFs) proteins could be used to turn genes on or off. The company has ongoing Phase 2 clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic for the treatment of HIV/AIDS. Its other therapeutic programs are focused on monogenic diseases, including hemophilia, Huntington's disease and hemoglobinopathies such as beta-thalassemia and sickle cell anemia. Sangamo BioSciences was founded by Lanphier O. Edward II on June 22, 1995 and is headquartered in Richmond, CA
| Top 10 Open Interest For May 17 Expiration | Top 5 High Yield | |||||
|---|---|---|---|---|---|---|
| 1. | QQQ covered calls | 6. | EEM covered calls | 1. | WOLF covered calls | |
| 2. | HYG covered calls | 7. | KWEB covered calls | 2. | FSLY covered calls | |
| 3. | IWM covered calls | 8. | SLV covered calls | 3. | INTC covered calls | |
| 4. | SPY covered calls | 9. | TSLA covered calls | 4. | GRPN covered calls | |
| 5. | FXI covered calls | 10. | NVDA covered calls | 5. | MPW covered calls | |
Want more examples? SGH Covered Calls | SGOL Covered Calls
